People with Parkinson's disease are receiving a new treatment in a clinical trial started after University of Wisconsin–Madison scientists demonstrated the safety and feasibility of the therapeutic delivery method in a ...
Jul 29, 2024
0
63
Independence Health System has introduced a new service that capitalizes on an overwhelming patient medical need and two new medicines.
Aug 10, 2024
0
26
Europe's medicines watchdog on Friday rejected a marketing request for a new Alzheimer's disease treatment, saying the risks of the medicine's side effects, including potential brain bleeding, outweighed the benefits.
Jul 26, 2024
0
1
People who consume psilocybin-containing mushrooms—otherwise known as magic mushrooms—typically undergo a surreal experience in which their sense of space, time and self is distorted. Advocates have long argued that, ...
Jul 17, 2024
0
121
US health regulators on Friday denied an application for treating post-traumatic stress disorder (PTSD) with the drug MDMA, commonly known as ecstasy, saying more investigation needed to be done.
Aug 10, 2024
0
31
A study surveying advances in diabetes pathogenesis and treatment explores the complex factors contributing to the onset and progression of the disease, suggesting that an understanding of these dynamics is key to developing ...
Jul 26, 2024
0
33
In recent years, there's been a big boost in the beverage industry when it comes to the sale of energy drinks. Classified as dietary supplements, most of these drinks contain stimulating ingredients, in addition to high amounts ...
Jul 15, 2024
0
1
For decades, researchers have worked to develop therapies that can prime the immune system to recognize and attack proteins on the surface of tumor cells. However, success has been limited due to the technological challenge ...
Aug 8, 2024
0
0
Elon Musk recently pronounced that the next Neuralink project will be a "Blindsight" cortical implant to restore vision: "Resolution will be low at first, like early Nintendo graphics, but ultimately may exceed normal human ...
Aug 7, 2024
0
0
The U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata.
Aug 3, 2024
0
1
